Jane Street’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Jane Street’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-713	Closed	-$139K	–	11206
2021 Q4	$139K	Buy	+713	New	+$111K	﹤0.01%	9049

Other funds holding TBIO

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's TBIO Position: Q1 2022 in Review

Jane Street sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q1 2022, closing a stake of 713 shares — an estimated $139K sold.

Jane Street first reported a position in TBIO in Q4 2021 and held it in 1 quarter. The position peaked at $139K in Q4 2021. 47 funds tracked by Wall St. Rank hold TBIO as of Q1 2022.

Jane Street reported no remaining Telesis Bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Jane Street sold 713 Telesis Bio, Inc. Common Stock shares in Q1 2022, an estimated $139K.
Jane Street first reported a position in Telesis Bio, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
Jane Street's Telesis Bio, Inc. Common Stock position peaked at $139K in Q4 2021.
47 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.